- Home
- MPX vs ESPR Comparison
MPX vs ESPR Comparison
Compare MPX & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- ESPR
- Stock Information
- Founded
- MPX 1965
- ESPR 2008
- Country
- MPX United States
- ESPR United States
- Employees
- MPX N/A
- ESPR N/A
- Industry
- MPX Marine Transportation
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- MPX Industrials
- ESPR Health Care
- Exchange
- MPX Nasdaq
- ESPR Nasdaq
- Market Cap
- MPX 326.0M
- ESPR 305.0M
- IPO Year
- MPX N/A
- ESPR 2013
- Fundamental
- Price
- MPX $8.42
- ESPR $1.39
- Analyst Decision
- MPX Hold
- ESPR Buy
- Analyst Count
- MPX 1
- ESPR 7
- Target Price
- MPX $8.00
- ESPR $6.36
- AVG Volume (30 Days)
- MPX 25.5K
- ESPR 4.5M
- Earning Date
- MPX 04-24-2025
- ESPR 03-04-2025
- Dividend Yield
- MPX 6.69%
- ESPR N/A
- EPS Growth
- MPX N/A
- ESPR N/A
- EPS
- MPX 0.50
- ESPR N/A
- Revenue
- MPX $236,555,000.00
- ESPR $332,314,000.00
- Revenue This Year
- MPX $3.97
- ESPR $5.51
- Revenue Next Year
- MPX $13.02
- ESPR $1.42
- P/E Ratio
- MPX $16.80
- ESPR N/A
- Revenue Growth
- MPX N/A
- ESPR 185.66
- 52 Week Low
- MPX $8.10
- ESPR $1.35
- 52 Week High
- MPX $12.47
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- MPX 47.21
- ESPR 33.54
- Support Level
- MPX $8.10
- ESPR $1.35
- Resistance Level
- MPX $8.48
- ESPR $1.75
- Average True Range (ATR)
- MPX 0.19
- ESPR 0.09
- MACD
- MPX 0.03
- ESPR -0.01
- Stochastic Oscillator
- MPX 72.73
- ESPR 10.00
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.